Dipeptidyl Peptidase 4 Inhibition Facilitate Healing of Diabetic Ulcers
Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
To investigate the effect of Dipeptidyl Peptidase 4 Inhibition on wound healing in patients
with diabetic foot ulcers, the investigators randomly divided the participants into two
groups: saxagliptin with regular treatment group，placebo with regular treatment group. The
clinical data are collected at the given time point. This study aimed to observe the
potential protective effect of DPP4i on diabetic ulcers.